These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women. Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641 [TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403 [TBL] [Abstract][Full Text] [Related]
12. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens. Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317 [TBL] [Abstract][Full Text] [Related]
13. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration. Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862 [TBL] [Abstract][Full Text] [Related]
14. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190 [TBL] [Abstract][Full Text] [Related]
15. What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone. Simon JA Climacteric; 2012 Apr; 15 Suppl 1():3-10. PubMed ID: 22432810 [TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and hemostasis among postmenopausal women: a review. Canonico M Menopause; 2014 Jul; 21(7):753-62. PubMed ID: 24937030 [TBL] [Abstract][Full Text] [Related]
17. Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen. Canonico M; Alhenc-Gelas M; Plu-Bureau G; Olié V; Scarabin PY Menopause; 2010; 17(6):1122-7. PubMed ID: 20613675 [TBL] [Abstract][Full Text] [Related]
18. Long-term hormone therapy for perimenopausal and postmenopausal women. Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732 [TBL] [Abstract][Full Text] [Related]
19. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study. Bouaziz E; Canonico M; Verstuyft C; Carcaillon L; Martin F; Scarabin PY; Guiochon-Mantel A; Maturitas; 2009 Oct; 64(2):136-8. PubMed ID: 19782484 [TBL] [Abstract][Full Text] [Related]
20. Long term hormone therapy for perimenopausal and postmenopausal women. Marjoribanks J; Farquhar C; Roberts H; Lethaby A Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]